Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-28
1995-06-27
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514471, 514473, 514 95, 514 99, 549 6, 549 64, 549222, 549318, A61K 3134, A61K 3138, C07D30760, C07D33332
Patent
active
054280583
ABSTRACT:
There are disclosed compounds of the formula: ##STR1## wherein R.sup.1 is hydrogen, alkyl, cycloalkyl, arylalkyl, --(CH.sub.2).sub.r CH.dbd.CH.sub.2, --(CH.sub.2).sub.s OY, --(CH.sub.2).sub.t CH(OZ)CH.sub.3, or Ar;
REFERENCES:
patent: 4874782 (1989-10-01), Bonjouklian et al.
patent: 5242945 (1993-09-01), Caufield et al.
CA 117(17): 169564g A Novel . . . Ophiobolus. Furui et al., p. 670, 1992.
Derwent Publication 87-067659/10 corresponding to J62019582, (1985).
Nomura et al., Chem Pharm Bulletin, 34:5188 (1986) pp. 5188-5190.
Kataoka et al., Chemical Abstracts, 84:175144m (1976).
Orno et al., Chemical Abstracts, 81:151976w (1974).
American Home Products Corporation
McKane Joseph K.
Milowsky Arnold S.
LandOfFree
Phospholipase A.sub.2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase A.sub.2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase A.sub.2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287892